huahaipharm(SH:600521)2021-05-11 09:31Group 1: Event Details - The investor reception day is scheduled for May 17, 2021, from 9:30 AM to 12:30 PM [3] - The event will take place at Zhejiang Huahai Pharmaceutical Co., Ltd. in Linhai City, Zhejiang Province [4] - The meeting will be held in person [4] Group 2: Company Representatives - Company representatives include Mr. Zhu Yonghua (Vice President and Board Secretary), Ms. Zhang Meinu (CFO), and Mr. Guo Xiaodi (Chief Scientist and Director of Formulation Research Institute) [5] - Other attendees include managers from subsidiaries, such as Mr. Zhu Xiangyang (General Manager of Shanghai Huao Tai Biopharmaceutical Co., Ltd.) and Ms. Gang Hui (General Manager of Zhejiang Huahai Pharmaceutical Sales Co., Ltd.) [5] Group 3: Participation Information - Investors interested in attending must register in advance between May 12 and May 14, 2021 [6] - Registration can be done via mail, email, or fax, and must include a completed attendance receipt and a copy of a valid ID [6] - Contact persons for registration are Jin Min and Wang Huiting, with provided phone numbers and email [6] Group 4: Post-Event Disclosure - After the event, the company will disclose the meeting's outcomes and key points through designated media, including China Securities Journal and Shanghai Securities News [7]